Drug Database
Back to search

Poland· PL-100252744

Bydureon

A exenatide product containing exenatidum, registered in Poland by AstraZeneca AB. The same ATC class is registered in 10 of our 19 countries.

ATC A10BJ01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBydureonATCA10BJ01REGISTER NO.PL-100252744PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about exenatidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Exenatide is registered in 10 of 19 countries.

Countries holding a registration under ATC A10BJ01 (exenatide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search exenatide products by name

Exenatide · ATC A10BJ01

10 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of exenatide costs, country by country.

Normalised to the WHO defined daily dose (15 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Exenatide · price per daily dose (15 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.26
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Exenatidum
Manufacturer
AstraZeneca AB
Country
Poland (PL)
ATC code
A10BJ01
ATC class
Exenatide
Defined daily dose
15 mcg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990893584
  • gtin
    05909990893591
  • gtin
    05902135480021

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

404 interactions on record for exenatide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check exenatide against other medicinesHow interaction checks work

Exenatide · interactions on record

404 records

  • 3 severe
  • 359 moderate
  • 42 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • MannitolA06AD16moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Exenatide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exenatide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7bb88640-f2c7-47cc-aadd-af100ba71335
GET /v1/drugs/7bb88640-f2c7-47cc-aadd-af100ba71335?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909990893584 ¦ Rp ¦ EU/1/11/696/001 ¦ 68602\n4 fiol. 2 mg proszek ¦ 4 strzykawki 0,65 ml rozpuszczalnik + 1 łącznik fiolki +2 igły\n05909990893591 ¦ Rp ¦ EU/1/11/696/002 ¦ 68603\n12 fiol. 2 mg proszku ¦ 12 strzykawek 0,65 ml rozpuszczalnik + 1 łącznik fiolki +2 igły\n05902135480021 ¦ Rp ¦ EU/1/11/696/003 ¦ 105602\n4 wstrzykiwacze 2 mg proszek + rozpuszczalnik 0,65 ml + 1 igła\nRp ¦ EU/1/11/696/004 ¦ 119468\n12 wstrzykiwaczy 2 mg proszek + 0,65 ml rozpuszczalnik + 3 igły\nRp ¦ EU/1/11/696/005 ¦ 131439\n4 wstrzyk. 0,85 ml\nRp ¦ EU/1/11/696/006 ¦ 135759\n12 wstrzykiwaczy 0,85 ml",
  "substance": "Exenatidum 2 mg",
  "common_name": "Exenatidum",
  "pl_product_id": "100252744",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about exenatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console